2018 US Microbiology Analyzers & Consumables: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, and Opportunities for Suppliers - ResearchAndMarkets.com

November 29, 2018

DUBLIN--(BUSINESS WIRE)--Nov 29, 2018--The “2018 US Microbiology Analyzers and Consumables: Market Share Analysis, Country Segment Forecasts, Competitive Intelligence, Technology Trends, Opportunities for Suppliers” report has been added to ResearchAndMarkets.com’s offering.

This report is an analysis of major business opportunities emerging in the U.S. automated microbiology market during the next five years.

The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.


The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.

The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding market, in evaluating emerging opportunities and developing effective business strategies.

Market Segmentation Analysis

Sales and market shares for major suppliers by individual test. Volume and sales forecasts for over 100 infectious disease assays by individual test: Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy). Review of the market dynamics, trends, structure, size, growth and major suppliers.

Specimen Types

Urine Sterile Fluids: Blood, Serum, CSF Throat Swabs, Respiratory Secretions Genital Secretions Stool Abscess/Wound Sputum Saliva


Microbial Identification Antibiotic Susceptibility Urine Screening Blood Cultures

Review of Major Automated Systems

Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers.

Infectious Diseases Analyzed in the Report

AIDS/HIV Adenovirus Aeromonads Bartonella Blastocystis Hominis Campylobacter Candida Chancroid Chlamydia Clostridium Coronavirus Coxsackievirus Cryptosporidium Cyclospora CMV E. Coli Echovirus Encephalitis Enterovirus EBV Giardia Gonorrhea Granuloma Inguinale Hantavirus H. Pylori Hepatitis Herpes Influenza Legionella Lyme disease Lymphogranuloma Malaria Measles Meningitis Microsporidium Mononucleosis Mumps Mycoplasma HPV Parvovirus Pneumonia Polyomaviruses Pseudomonas Rabies RSV Rhinovirus Rotavirus Rubella Salmonella Septicemia Shigella Staphylococci Streptococci Syphilis Toxoplasmosis Trichomonas TB Vibrio West Nile Yersinia

Technology Review

Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market. Global listings of companies developing or marketing microbiology products by individual test.

Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including:

Abbott Affymetrix Agilent Technologies Beckman Coulter/Danaher Becton Dickinson Biokit bioMerieux Bio-Rad Biotest CellMark Forensics/LabCorp Eiken Chemical Enzo Biochem Fujirebio Grifols Hologic/Gen-Probe ID Biomedical/GSK Illumina Kreatech/Leica Li-Cor Biosciences Lonza Monogram Biosciences Myriad Genetics Ortho-Clinical Diagnostics Perkin Elmer/Caliper Qiagen Roche Scienion Shimadzu Siemens Sierra Molecular Takara Bio Tecan Thermo Fisher Wallac/PE Wako and more...

Companies assessed include data for sales, product portfolios, marketing tactics, collaborative arrangements and new products in RD.

Opportunities and Strategic Recommendations

Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years. Design criteria for decentralized testing products. Alternative market penetration strategies. Potential market entry barriers and risks.

For more information about this report visit https://www.researchandmarkets.com/research/m6spv2/2018_us?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181129005329/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:In Vitro Diagnostics



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/29/2018 06:25 AM/DISC: 11/29/2018 06:25 AM


Update hourly